Perpetual Ltd’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Hold |
2,930
| – | – | ﹤0.01% | 357 |
|
|
2025
Q1 | $324K | Sell |
2,930
-10,171
| -78% | -$1.12M | ﹤0.01% | 367 |
|
|
2024
Q4 | $1.79M | Buy |
13,101
+541
| +4% | +$73.8K | 0.02% | 201 |
|
|
2024
Q3 | $1.45M | Buy |
12,560
+6,170
| +97% | +$711K | 0.02% | 224 |
|
|
2024
Q2 | $880K | Sell |
6,390
-410
| -6% | -$56.4K | 0.01% | 283 |
|
|
2024
Q1 | $938K | Buy |
6,800
+14
| +0.2% | +$1.93K | 0.01% | 286 |
|
|
2023
Q4 | $894K | Buy |
+6,786
| New | +$894K | 0.01% | 285 |
|
|
2023
Q3 | – | Sell |
-2,268
| Closed | -$214K | – | 486 |
|
|
2023
Q2 | $214K | Buy |
+2,268
| New | +$214K | ﹤0.01% | 454 |
|